Kolkata, India Book Consultation
Invite for Event Lectures and Interviews
WhatsApp For sharing reports of existing patients only
  1. Home
  2. Areas of Expertise

Areas of Expertise

Seven areas of
focused practice.

Conditions across diabetes, endocrine and metabolic medicine — assessed together rather than as separate problems, and managed with current evidence.

The long view, not the last reading

Diabetes Care

Assessment and long-term management of type 2 diabetes, with attention to complications, treatment escalation and the cardio-renal consequences of poor control.

  • Type 2 diabetes: diagnosis and long-term review
  • Glycaemic management and treatment escalation
  • Screening for and managing complications
  • Continuous glucose monitoring in routine care

Diabetes care in detail

Thyroid, and the chemistry of bone

Endocrinology

Endocrine practice focused on thyroid function and on bone and calcium metabolism — the disorders that most often present in general practice and most reward careful, long-term follow-up.

  • Hypothyroidism: diagnosis, replacement and long-term review
  • Hyperthyroidism: investigation and management of an overactive thyroid
  • Bone & calcium: metabolic bone disease, calcium and vitamin D disorders

Endocrinology in detail

Weight as a medical problem, treated medically

Obesity & Metabolic Health

Structured medical management of obesity, including GLP-1 receptor agonists and dual incretin therapies, with SCOPE certification from the World Obesity Federation.

  • Structured medical obesity management
  • GLP-1 receptor agonists
  • Dual incretin therapies
  • SCOPE certification, World Obesity Federation

Obesity & metabolic health in detail

Metabolic medicine, as women experience it

Women's Metabolic Health

Endocrine aspects of obesity and women's health — including reproductive and metabolic outcomes — form one of Dr. Bhaduri's principal research interests and a recurring theme in his international faculty work.

  • Endocrine aspects of obesity in women
  • Reproductive and metabolic outcomes
  • Whether women respond differently to GLP-1-based therapies
  • Gestational diabetes: screening approaches and management
  • Managing inconsistent readings in gestational diabetes
  • Obesity, stigma and the impact on women's health

Academic context. Faculty speaker at the International Conference on Advancing Women's Health 2025, and National Advisor to the Pregnancy Study Group in Diabetes (PSG InDia).

Illustration: a couple in a consulting room during a metabolic health review.
Shared risk Heart Kidney Metabolism
Illustration: cardio-renal risk results reviewed with a patient and their family.

One system, not three problems

Cardio-Renal-Metabolic Health

The heart, the kidneys and metabolism decline together in type 2 diabetes — and they can be protected together. This interrelationship is central to Dr. Bhaduri's clinical practice and research.

  • Cardio-renal-metabolic risk assessment
  • Slowing kidney disease progression in type 2 diabetes
  • Nephropathy beyond albuminuria
  • Dyslipidaemia and lipid management
  • Translating cardiovascular outcome trial evidence into practice
  • SGLT2 inhibitors and GLP-1 receptor agonists for organ protection

The liver's place in metabolic disease

MASLD & Metabolic Liver Health

Metabolic dysfunction-associated steatotic liver disease sits at the intersection of diabetes, dyslipidaemia and kidney disease. It is a principal focus of Dr. Bhaduri's published research.

  • MASLD assessment in patients with type 2 diabetes
  • Dyslipidaemia and liver enzymes in diabetes with Stage 3 CKD
  • Role of saroglitazar in MASLD
  • SGLT2 inhibitors in metabolic liver disease
  • Gut microbiota-derived metabolites in MASLD progression
  • The mitochondrial-autophagy axis in MASLD

Related publications

Illustration: a consultation reviewing liver and metabolic results.

Tools that sharpen clinical judgement

Technology & AI in Diabetes

Continuous glucose monitoring, digital health tools and AI-assisted decision support — an active research and teaching interest, applied where it changes decisions.

Illustration: continuous monitoring data reviewed at the bedside.
01

Continuous glucose monitoring

Interpreting CGM data and integrating it into treatment decisions rather than collecting it for its own sake.

02

Smart insulin devices

Chair, Advances in Diabetes Related Technology: Smart Insulin Devices and CGMs, DRWA 12th Annual Conference 2025.

03

Artificial intelligence

Faculty on AI in Diabetes workshops, and invited speaker at the World AI Summit in Healthcare, Kolkata.

04

Clinical decision support

Research into AI and digital health tools for optimising diabetes care and supporting clinical decisions.

05

Mobile health applications

Consensus group member on a position statement covering efficacy, regulation and ethical implementation.

06

Point-of-care testing

Integrated systems that make self-monitoring practical in routine review.

Explore the research

Discuss your diagnosis

Bring your recent reports and medication list to the first consultation — it makes the assessment considerably more useful.

Call WhatsApp Book